Loading…
Drugs Made In America Acquisition Corp. is projected to rise to $12.50 by 2027, a +17% move from its current price of $10.66. DMAA is currently trading above its 50-day average (a bullish sign). Technical indicators currently lean strong buy.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 7/11/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Jul 13 | $10.63 | $10.66 | $10.69 | +0.01% |
| Jul 14 | $10.62 | $10.66 | $10.70 | +0.01% |
| Jul 15 | $10.61 | $10.66 | $10.71 | +0.02% |
| Jul 16 | $10.61 | $10.66 | $10.72 | +0.02% |
| Jul 17 | $10.60 | $10.66 | $10.73 | +0.03% |
| Jul 18 | $10.60 | $10.66 | $10.73 | +0.03% |
| Jul 19 | $10.59 | $10.66 | $10.74 | +0.04% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $10.59 | $10.66 | $10.74 | +0.04% |
| Week 2 | $10.56 | $10.67 | $10.77 | +0.07% |
| Week 3 | $10.54 | $10.67 | $10.80 | +0.11% |
| Week 4 | $10.53 | $10.68 | $10.82 | +0.14% |
| Week 5 | $10.51 | $10.68 | $10.85 | +0.18% |
| Week 6 | $10.50 | $10.68 | $10.87 | +0.21% |
| Week 7 | $10.49 | $10.69 | $10.88 | +0.25% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Drugs Made In America Acquisition Corp. is a financial services company that currently has no significant operations. It intends to effect a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization, or other similar business combinations with one or more businesses. It is categorized under Financial Services.
The company was incorporated in 2024 and is based in New York, New York.
DMAA trades at $10.63 per share and has a market capitalization of $258.06M. It is ranked 3407.
The current price outlook is informed by a year-by-year forecast that shows gradual upside from the current level. Forecasts provide a path of rising averages and highs across 2026 through 2050, with sentiment shifting from Neutral to Bullish in later years.
A major floor 1.9% below — a decisive break under it would weaken the trend.
Price is testing support right now (0.6% away) — a key level to hold.
Price is pressing into resistance (0.0% away) — a breakout level to watch.
A major ceiling 0.4% above — clearing it would confirm fresh momentum.
Key DMAA support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of DMAA market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $10.66 | Buy | $10.66 | Buy |
| MA 10 | $10.65 | Buy | $10.65 | Buy |
| MA 20 | $10.64 | Buy | $10.64 | Buy |
| MA 50 | $10.61 | Buy | $10.61 | Buy |
| MA 100 | $10.55 | Buy | $10.56 | Buy |
| MA 200 | $10.45 | Buy | $10.46 | Buy |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 67.48 | Neutral |
| Stoch RSI (14) | 69.52 | Neutral |
| CCI (20) | 107.77 | Buy |
| Williams %R (14) | 0.00 | Info |
| MACD (12,26,9) | 0.00 | Buy |
| ROC (12) | 0.19 | Buy |
| Bollinger %B (20,2) | 0.84 | Neutral |
| Stochastic %K (14) | 100.00 | Sell |
| TRIX (15) | 0.02 | Buy |
| Awesome (5,34) | 0.03 | Buy |
| Ultimate (7,14,28) | 64.73 | Neutral |
| Momentum (10) | 0.02 | Buy |
| Aroon Osc (25) | 84.00 | Buy |
| Hull MA (9) | 10.66 | Sell |
| ADX (14) | 31.42 | Buy |
| ATR (14) | 0.01 | Info |
The 30-day technical picture is described as BULLISH with RSI14 at 70.0. The 50-day simple moving average (SMA50) sits at $10.58 and the 200-day simple moving average (SMA200) at $10.43.
In the near term, support is at $10.58 and resistance at $10.63. The 30-day price range spans from $10.58 to $10.68.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $10.37 | $10.66 | $13.47 | 0% | Neutral | |
| $10.20 | $12.50 | $16.04 | +17% | Neutral | |
| $11.46 | $14.32 | $18.90 | +34% | Bullish | |
| $13.40 | $17.03 | $22.97 | +60% | Bullish | |
| $16.15 | $20.81 | $28.60 | +95% | Bullish | |
| $16.45 | $21.48 | $30.02 | +101% | Bullish | |
| $16.86 | $22.27 | $31.59 | +109% | Bullish | |
| $18.97 | $25.35 | $36.44 | +138% | Bullish | |
| $19.17 | $25.89 | $37.68 | +143% | Bullish | |
| $21.33 | $29.10 | $42.85 | +173% | Bullish | |
| $29.73 | $42.42 | $65.59 | +298% | Bullish | |
| $61.61 | $94.76 | $157.54 | +789% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| July 2026 | $10.37 | $10.66 | $12.56 | +0.00% |
| August 2026 | $8.92 | $10.46 | $12.53 | -1.90% |
| September 2026 | $9.09 | $10.71 | $12.94 | +2.42% |
| October 2026 | $9.35 | $11.06 | $13.45 | +3.27% |
| November 2026 | $9.26 | $10.99 | $13.45 | -0.60% |
| December 2026 | $9.19 | $10.95 | $13.47 | -0.36% |
Click any year to see its month-by-month DMAA forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
In 2026, DMAA is projected to trade between $10.37 and $13.47, averaging $10.66 — a potential gain of 0% from today's $10.66. Price action looks broadly range-bound.
Drugs Made In America Acquisition Corp.'s 2027 outlook centres on $12.50, within a $10.20 to $16.04 range. That is up +17% on the projected 2026 average. That marks a +17% change versus current levels. A consolidation phase looks the most probable path here.
By 2028, DMAA could reach as high as $18.90, with a base case around $14.32 and support toward $11.46 — roughly +34% from $10.66. Momentum favours further upside here.
Expect DMAA to range from $13.40 to $22.97 through 2029. The $17.03 average target implies a +60% move from current prices. That is up +19% on the projected 2028 average. Buyers look set to stay in control over this stretch.
The DMAA price prediction for 2030 points to an average of $20.81 (low $16.15, high $28.60) — a potential gain of +95% on today's $10.66. Momentum favours further upside here.
In 2031, DMAA is projected to trade between $16.45 and $30.02, averaging $21.48 — a potential gain of +101% from today's $10.66. That is up +3% on the projected 2030 average. Buyers look set to stay in control over this stretch.
Drugs Made In America Acquisition Corp.'s 2032 outlook centres on $22.27, within a $16.86 to $31.59 range. That is up +4% on the projected 2031 average. That marks a +109% change versus current levels. Momentum favours further upside here.
By 2033, DMAA could reach as high as $36.44, with a base case around $25.35 and support toward $18.97 — roughly +138% from $10.66. Buyers look set to stay in control over this stretch.
Expect DMAA to range from $19.17 to $37.68 through 2034. The $25.89 average target implies a +143% move from current prices. That is up +2% on the projected 2033 average. Momentum favours further upside here.
The DMAA price prediction for 2035 points to an average of $29.10 (low $21.33, high $42.85) — a potential gain of +173% on today's $10.66. Buyers look set to stay in control over this stretch.
In 2040, DMAA is projected to trade between $29.73 and $65.59, averaging $42.42 — a potential gain of +298% from today's $10.66. That is up +46% on the projected 2035 average. Momentum favours further upside here.
Drugs Made In America Acquisition Corp.'s 2050 outlook centres on $94.76, within a $61.61 to $157.54 range. That is up +123% on the projected 2040 average. That marks a +789% change versus current levels. Buyers look set to stay in control over this stretch.
Investing $1,000 in DMAA today (≈ 93.80951 DMAA) could be worth
$8,889.7
+$7,889.7 (+789%) by 2050 · US Dollar
Based on the average projected DMAA price of $94.76 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in DMAAwould be worth at today's price.
$1,000 invested in DMAA on Jul 10, 2025 (≈ 97.943193 DMAA) would be worth
$1,044.06
+$44.06 (+4.4%) today · 1.04× · US Dollar
Based on a DMAA entry price of $10.21 vs. today's $10.66.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $10.65 | $1,000.93 | +0.1% |
| 1 month ago | $10.6 | $1,005.18 | +0.5% |
| 3 months ago | $10.52 | $1,013.78 | +1.4% |
| 6 months ago | $10.38 | $1,026.97 | +2.7% |
| 1 year ago | $10.21 | $1,044.06 | +4.4% |
| All time (1.4y) ago | $9.96 | $1,070.27 | +7.0% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our DMAA forecast.
Our base-case forecast reaches $21.00 around 2031.
Implied market cap at $21.00: $509.82M
The multi-year forecast shows a path of rising prices. The 2026 average is $10.63, followed by 2027 $12.46, 2028 $14.31, 2029 $17.38, 2030 $20.77, 2031 $21.21, 2032 $22.56, 2033 $25.48, 2034 $25.53, and 2035 $29.40 (averages).
Beyond 2035, the forecast envisions 2040 average at $41.86 and 2050 average at $96.01, with maximums of $65.30 in 2040 and $161.28 in 2050. The corresponding ROIs rise from 0 in 2026 to 17.2 in 2027, 34.7 in 2028, 63.5 in 2029, 95.4 in 2030, 99.5 in 2031, 112.2 in 2032, 139.7 in 2033, 140.2 in 2034, 176.6 in 2035, 293.8 in 2040, and 803.2 in 2050.
Sentiment shifts from Neutral in 2026–2027 to Bullish from 2028 onward. These are estimates, not guarantees, and should be considered within the broader context of market risk and uncertainty.
Tap a question to reveal the answer.
Avg price $20.77; min $16.04; max $28.73; ROI 95.4; sentiment BULLISH.
Forecasts show rising averages over time with bullish sentiment from 2028 onward and positive ROIs: 2030 Avg $20.77 (ROI 95.4); 2040 Avg $41.86 (ROI 293.8); 2050 Avg $96.01 (ROI 803.2). These are estimates, not guarantees.
Yes, the 2050 max forecast is $161.28, and the 2050 average is $96.01, indicating the potential to exceed $100 in the forecast horizon. These figures are not guaranteed.
Current price $10.63; market cap $258.06M.
Forecast sentiment is Neutral in 2026 and 2027, then Bullish from 2028 onward through 2050.
Drugs Made In America Acquisition Corp. Community Discussion
0Share your Drugs Made In America Acquisition Corp. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.